Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles.

Erik C Dreaden1, Stephen W Morton, Kevin E Shopsowitz

  • 1Koch Institute for Integrative Cancer Research, ‡Department of Chemical Engineering, and §Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology , 500 Main Street, Cambridge, Massachusetts 02142, United States.

ACS Nano
|August 8, 2014
PubMed
Summary

This study introduces a novel polymer drug carrier that targets tumors using pH-responsive and CD44 receptor-targeting strategies. This dual-action approach enhances tumor penetration and cellular uptake for improved cancer diagnostics and therapy.